NINL and lymphoma: In the first period (1.5-year) study, we found 26.1% and 16.7% lymphoma incidence in Nlp-/- and Nlp+/- mice respectively, while none of a case of lymphoma in Nlp+/+ mice (p value were 0.0094 and 0.0423).